Ironwood and Forest Announce Positive Linaclotide Results from Two Pivotal Phase 3 Trials in...

Ironwood Pharmaceuticals, Inc. and Forest Laboratories, Inc. (NYSE: FRX) today announced positive top-line results from two Phase 3 clinical trials assessing the safety and efficacy of once-daily dosing of the investigational... [read full story]                    

powered by
Add Comment
There are also 9 related articles
View all news articles about*:
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies